AAAAAA

   
Results: 1-15 |
Results: 15
Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence
Authors: Suzuki, S Chuang, LF Doi, RH Bidlack, JM Chuang, RY
Citation: S. Suzuki et al., Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence, INT IMMUNO, 1(9-10), 2001, pp. 1733-1742
Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity
Authors: Martin-Kleiner, I Bidlack, JM
Citation: I. Martin-kleiner et Jm. Bidlack, Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity, INT IMMUNO, 1(1), 2001, pp. 13-20
8-carboxamidocyclazocine analogues: Redefining the structure-activity relationships of 2,6-methano-3-benzazocines
Authors: Wentland, MP Lou, RL Ye, YC Cohen, DJ Richardson, GP Bidlack, JM
Citation: Mp. Wentland et al., 8-carboxamidocyclazocine analogues: Redefining the structure-activity relationships of 2,6-methano-3-benzazocines, BIOORG MED, 11(5), 2001, pp. 623-626
Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: Synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan
Authors: Neumeyer, JL Gu, XH van Vliet, LA DeNunzio, NJ Rusovici, DE Cohen, DJ Negus, SS Mello, NK Bidlack, JM
Citation: Jl. Neumeyer et al., Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: Synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan, BIOORG MED, 11(20), 2001, pp. 2735-2740
3-carboxamido analogues of morphine and naltrexone: Synthesis and opioid receptor binding properties
Authors: Wentland, MP Lou, RL Dehnhardt, CM Duan, WH Cohen, DJ Bidlack, JM
Citation: Mp. Wentland et al., 3-carboxamido analogues of morphine and naltrexone: Synthesis and opioid receptor binding properties, BIOORG MED, 11(13), 2001, pp. 1717-1721
kappa-opioid receptor agonist suppression of HIV-1 expression in CD4(+) lymphocytes
Authors: Peterson, PK Gekker, G Lokensgard, JR Bidlack, JM Chang, AC Fang, XG Portoghese, PS
Citation: Pk. Peterson et al., kappa-opioid receptor agonist suppression of HIV-1 expression in CD4(+) lymphocytes, BIOCH PHARM, 61(9), 2001, pp. 1145-1151
Detection and function of opioid receptors on cells from the immune system
Authors: Bidlack, JM
Citation: Jm. Bidlack, Detection and function of opioid receptors on cells from the immune system, CL DIAG LAB, 7(5), 2000, pp. 719-723
8-aminocyclazocine analogues: Synthesis and structure-activity relationships
Authors: Wentland, MP Xu, GY Cioffi, CL Ye, YC Duan, WH Cohen, DJ Colasurdo, AM Bidlack, JM
Citation: Mp. Wentland et al., 8-aminocyclazocine analogues: Synthesis and structure-activity relationships, BIOORG MED, 10(2), 2000, pp. 183-187
Selective protection and functionalization of morphine: Synthesis and opioid receptor binding properties of 3-amino-3-desoxymorphine derivatives
Authors: Wentland, MP Duan, W Cohen, DJ Bidlack, JM
Citation: Mp. Wentland et al., Selective protection and functionalization of morphine: Synthesis and opioid receptor binding properties of 3-amino-3-desoxymorphine derivatives, J MED CHEM, 43(19), 2000, pp. 3558-3565
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence
Authors: Neumeyer, JL Bidlack, JM Zong, RS Bakthavachalam, V Gao, P Cohen, DJ Negus, SS Mello, NK
Citation: Jl. Neumeyer et al., Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence, J MED CHEM, 43(1), 2000, pp. 114-122
Leo G. Abood, 1922-1998 - In memoriam
Authors: Bidlack, JM
Citation: Jm. Bidlack, Leo G. Abood, 1922-1998 - In memoriam, NEUROPSYCH, 20(2), 1999, pp. 198-198
The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line
Authors: Martin-Kleiner, I Bidlack, JM
Citation: I. Martin-kleiner et Jm. Bidlack, The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line, INT J IMMUN, 21(2), 1999, pp. 133-140
Genetic alteration of phospholipase C beta 3 expression modulates behavioral and cellular responses to mu opioids
Authors: Xie, W Samoriski, GM McLaughlin, JP Romoser, VA Smrcka, A Hinkle, PM Bidlack, JM Gross, RA Jiang, HP Wu, DQ
Citation: W. Xie et al., Genetic alteration of phospholipase C beta 3 expression modulates behavioral and cellular responses to mu opioids, P NAS US, 96(18), 1999, pp. 10385-10390
Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation
Authors: Ignatowski, TA Bidlack, JM
Citation: Ta. Ignatowski et Jm. Bidlack, Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation, J PHARM EXP, 290(2), 1999, pp. 863-870
Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: In vivo and in vitro characterization of mu-selective agonist and antagonist activity
Authors: McLaughlin, JP Hill, KP Jiang, Q Sebastian, A Archer, S Bidlack, JM
Citation: Jp. Mclaughlin et al., Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: In vivo and in vitro characterization of mu-selective agonist and antagonist activity, J PHARM EXP, 289(1), 1999, pp. 304-311
Risultati: 1-15 |